Key result
Amplatzer VSD occluder successfully treats iatrogenic left atrial pseudoaneurysm after LAA closure.
Why the study?
Left atrial appendage closure is increasingly used for stroke prevention in atrial fibrillation, but rare structural complications requiring percutaneous treatment may occur.
Case Report (n=1)
A rare iatrogenic left atrial pseudoaneurysm following LAAC can be identified using multimodality imaging and successfully managed with percutaneous transcatheter closure.
BACKGROUND: Left atrial appendage closure (LAAC) is increasingly used for stroke prevention in atrial fibrillation, but rare structural complications may occur and require percutaneous treatment. CASE SUMMARY: A 76-year-old man with atrial fibrillation/flutter was referred for LAAC after LAA thrombus was found on transesophageal echocardiography despite therapeutic anticoagulation. A "no-touch" strategy was planned. The device was deployed in FLX-ball configuration and advanced gently without resistance. However, transesophageal echocardiography and angiography demonstrated deployment within an outpouching adjacent to the true LAA. The device was recaptured, advanced into the true LAA, and LAAC was completed. Postprocedural computed tomography demonstrated a likely iatrogenic pseudoaneurysm, which was successfully closed 2 days later using an Amplatzer ventricular septal defect occluder. DISCUSSION: This case highlights multimodality imaging and transcatheter management of an iatrogenic left atrial pseudoaneurysm after LAAC. TAKE-HOME MESSAGES: LA pseudoaneurysm is a rare complication of LAAC. Multimodality imaging can identify the defect and guide percutaneous closure.
No takes yet. Share an insight, caveat, or question.
Giacaman et al. (2026) conducted a case report in Left atrial pseudoaneurysm after left atrial appendage closure (n=1). Percutaneous closure using an Amplatzer ventricular septal defect occluder was evaluated on Successful closure of the pseudoaneurysm. An iatrogenic left atrial pseudoaneurysm after left atrial appendage closure was successfully managed percutaneously using an Amplatzer ventricular septal defect occluder.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: